Craft

Sonoma Pharmaceuticals

Stock Price

$2.9

2024-10-29

Market Capitalization

$3.9 M

2024-10-29

Revenue

$12.7 M

FY, 2024

Sonoma Pharmaceuticals Summary

Company Summary

Overview
Sonoma Pharmaceuticals (formerly known as Oculus Innovative Sciences) is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. It offers safe, unique, prescription-strength solutions that support paths to healing for key dermatological conditions, eyelid and eyelash hygiene, wounds and burns, as well as animal afflictions. The Company's products improve outcomes for patients by reducing infection, itch, pain, scarring, and harmful inflammatory responses.
Type
Public
Status
Active
Founded
1999
HQ
Petaluma, CA, US | view all locations
Website
https://sonomapharma.com/
Cybersecurity rating
Sectors

Key People

LocationsView all

3 locations detected

  • Petaluma, CA HQ

    United States

    1129 N McDowell Blvd

  • Woodstock, GA

    United States

    645 Molly Ln #150

  • Herten, LI

    Netherlands

    Boven de Wolfskuil 3, c32

Sonoma Pharmaceuticals Financials

Summary Financials

Revenue (Q3, 2025)
$3.6M
Gross profit (Q3, 2025)
$1.3M
Net income (Q3, 2025)
($928.0K)
Cash (Q3, 2025)
$5.2M
EBIT (Q3, 2025)
($1.0M)
Enterprise value
($1.3M)

Footer menu